Showing 1431-1440 of 2079 results for "".
Effective Speechmaking for Physicians
https://practicaldermatology.com/topics/practice-management/effective-speechmaking-for-physicians/21666/Dermatologists can utilize these tips to exude confidence, make a good first impression, and connect with any audience.A Rare Case of Linear Darier Disease
https://practicaldermatology.com/youngmd-connect/resident-resource-center/a-rare-case-of-linear-darier-disease/23857/A localized genodermatosis with potential to cause widespread disease in the next generation.The Benefits of Private Practice: A Q&A with Joel Schlessinger, MD, FAAD
https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/While selling to and working for private equity–backed platforms may have its perks, many long-time private practitioners warn that the advantages of private practice are often not fully appreciated until it is too late. Practical Dermatology Chief Cosmetic Surgery Editor Emeritus Joel Schlessinger,Melanoma and the Predictive Value of Nevi: Unexpected Findings?
https://practicaldermatology.com/topics/practice-management/melanoma-and-the-predictive-value-of-nevi-unexpected-findings/20936/A new analysis shows that the association between nevi and melanoma is complex.Discourse and Education Key to Growth in the Aesthetic Spectrum
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/discourse-and-education-key-to-growth-in-the-aesthetic-spectrum/21237/Update on Atopic Dermatitis 2018
https://practicaldermatology.com/topics/general-topics/update-on-atopic-dermatitis-2018/20354/A look at the pathophysiology of AD, including structural and immunologic contributors, as well as new therapeutic developments with an eye toward breakthroughs on the horizon.Extended Half-Life and Long-Acting Biologics for the Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/extended-half-life-and-long-acting-biologics-for-the-treatment-of-psoriasis/60876/Explore the biologic rationale, emerging clinical candidates, and key unanswered questions surrounding extended half-life therapies for psoriatic disease.A Novel Topical Cream to Reduce Bruising
https://practicaldermatology.com/topics/general-topics/a-novel-topical-cream-to-reduce-bruising/21476/Although options to treat bruising have been limited, a new cream may be especially useful for older patients.Why Has the Market Gone Up When Economic News Looks Grim?
https://practicaldermatology.com/topics/practice-management/why-has-the-market-gone-up-when-economic-news-looks-grim/23314/A look at seven factors affecting the market.Melanoma in Skin of Color: More to Learn
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-in-skin-of-color-more-to-learn/23486/With evidence showing that cumulative UV exposure is not strongly correlated with melanoma risk in patients with skin of color, dermatologists must re-consider their messaging.